NEKTAR THERAPEUTICS Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2013 to Q2 2025
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Nektar Therapeutics quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2013 to Q2 2025.
- Nektar Therapeutics Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 14.1M shares, a 1.19% increase year-over-year.
- Nektar Therapeutics annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 206M shares, a 8.24% increase from 2023.
- Nektar Therapeutics annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 190M shares, a 1.53% increase from 2022.
- Nektar Therapeutics annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 187M shares, a 2.1% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)